WHO: COVAX to supply 355 million vaccine doses for Eastern Mediterranean region in 2021

By Reuters

A medical syringe and a vial in front of the COVAX word are seen in this creative illustrative photo. More than one hundred fifty COVID-19 coronavirus vaccine are in development across the world, several of which have the third phase of clinical trials, as media reported. (Photo illustration by STR/NurPhoto via Getty Images)

The COVAX vaccine sharing platform expects to have 25 million coronavirus vaccine doses for the Eastern Mediterranean region in March, rising to 355 million doses by December, a World Health Organization (WHO) official said on Wednesday.

The first doses provided for the region through COVAX will arrive in February, WHO official Yvan Hutin told reporters.

The WHO’s Eastern Mediterranean region comprises of Middle Eastern countries as well as Afghanistan, Pakistan, Somalia and Djibouti.

COVAX is co-led by the GAVI vaccine alliance, the WHO and others, and is designed to ensure equitable access to COVID-19 vaccinations globally. COVAX has said it aims to deliver 1.8 billion doses to poorer countries this year.

At least five countries in the Eastern Mediterranean region will benefit from the first wave of COVAX vaccines through the list of countries is yet been confirmed, said Richard Brennan, a second WHO official.

Countries with larger populations, lower-income and weaker health systems that are expected to make slower progress vaccinating will be prioritized in the COVAX vaccine rollout, officials said.

Eight countries in the Eastern Mediterranean have started vaccination campaigns. Ten countries in the region have documented one or more coronavirus variants, though its likely that the variants have spread further, Brennan said.

Leave a Reply

Your email address will not be published. Required fields are marked *